$PLX 3 SEC Filings

Filed On	Filing
25 Aug 2025	Form 3: Mamlok Gilad, Sr. VP and CFO
03 Jul 2025	Form 3: Elze Christian, Director No securities owned
15 Sep 2023	Form 3: Forster Eliot, Director No securities owned
05 Jul 2022	Form 3: Ben Zvi Shmuel, Director No securities owned
16 Feb 2021	Form 3: Dexcel Pharma Technologies Ltd., 10% owner and 1 other Holds 4,556,031 shares of Common Stock
08 Jul 2020	Form 3: Hayon Yael, Vice President, R&D No securities owned
03 Jan 2020	Form 3: Melincoff Gwen A, Director No securities owned
03 Jan 2020	Form 3: Boudes Pol F, Director Holds 40 shares of Common Stock
24 Sep 2019	Form 3: Rubin Eyal, Sr. VP & CFO No securities owned
02 Jul 2019	Form 3: Bashan Dror, Director No securities owned
13 Aug 2018	Form 3: Granot David, Director No securities owned
08 Jun 2018	Form 3: Naos Yaron, Sr. VP, Operations Holds 71,125 shares of Common Stock
20 Oct 2015	Form 3: Camber Capital Management Llc, 10% owner Holds 9,274,577 shares of Common Stock
17 Nov 2014	Form 3: Schwartz Aharon, Director No securities owned
03 Nov 2014	Form 3: Manor Moshe, President & CEO No securities owned
24 Jul 2014	Form 3: Yanai Shlomo, Director No securities owned
07 Sep 2010	Form 3: Palash Tzvi, Chief Operating Officer No securities owned
23 Dec 2009	Form 3: Lauterbach Sandra Leigh, VP, Sales & Commercial Affairs No securities owned
08 Sep 2008	Form 3: Kornberg Roger D., Director No securities owned
17 Jul 2008	Form 3: Bar-Shalev Amos, Director Holds 6,186,046 shares of Common Stock

Comments